A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19

NACompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

August 2, 2020

Primary Completion Date

February 2, 2021

Study Completion Date

February 2, 2021

Conditions
Mild-to-moderate COVID-19
Interventions
OTHER

KB109 + Self Supportive Care (SSC)

KB109 is a novel glycan

OTHER

Self Supportive Care (SSC) Alone

Self Supportive Care (SSC) Alone

Trial Locations (16)

15801

TruCare Internal Medicine and Infectious Diseases, DuBois

24501

Infectious Diseases Associates of Central Virginia, Lynchburg

27612

M3 Wake Research, Inc, Raleigh

28304

Carolina Institute For Clinical Research, Fayetteville

30328

Mount Vernon Clinical Research, Atlanta

33176

Vista Health Research, Miami

33184

Bio-Medical Research, Miami

37421

ClinSearch LLC, Chattanooga

70601

Centex Studies, Inc. - Lake Charles, Lake Charles

71913

Healthstar Research, Hot Springs

75115

Global Medical Research, DeSoto

77058

Centex Studies, Houston

89104

Wake Research - Clinical Research Center of Nevada, LLC, Las Vegas

92108

Medical Center for Clinical Research, San Diego

92505

Axon Clinical Research, Riverside

01655

University of Massachusetts Medical School, Worcester

Sponsors
All Listed Sponsors
lead

Kaleido Biosciences

INDUSTRY